View in EDS

Therapeutic sequencing and role of cabozantinib after immunotherapy in metastatic renal cell carcinoma.

Saved in:
Bibliographic Details
Title: Therapeutic sequencing and role of cabozantinib after immunotherapy in metastatic renal cell carcinoma.
Authors: Catalano M; Department of Health Sciences, Section of Clinical Pharmacology and Oncology, University of Florence, Viale Pieraccini, 6, Florence 50139, Italy., Venturini J; Department of Experimental and Clinical Medicine, University of Florence, Florence, Italy., Vascotto IA; Department of Experimental and Clinical Medicine, University of Florence, Florence, Italy., Sthembari K; Department of Experimental and Clinical Medicine, University of Florence, Florence, Italy., Mancini S; Department of Experimental and Clinical Medicine, University of Florence, Florence, Italy., Pratesi L; Department of Experimental and Clinical Medicine, University of Florence, Florence, Italy., Paulet A; Department of Experimental and Clinical Medicine, University of Florence, Florence, Italy., Mela MM; Careggi University Hospital, Clinical Oncology, Florence, Italy., Rossi V; Careggi University Hospital, Clinical Oncology, Florence, Italy., Pillozzi S; Department of Experimental and Clinical Medicine, University of Florence, Florence, Italy., Antonuzzo L; Department of Experimental and Clinical Medicine, University of Florence, Florence, Italy; Careggi University Hospital, Clinical Oncology, Florence, Italy., Roviello G; Department of Health Sciences, Section of Clinical Pharmacology and Oncology, University of Florence, Viale Pieraccini, 6, Florence 50139, Italy. Electronic address: giandomenico.roviello@unifi.it.
Source: Critical reviews in oncology/hematology [Crit Rev Oncol Hematol] 2026 Jul; Vol. 223, pp. 105334. Date of Electronic Publication: 2026 Apr 10.
Publication Type: Journal Article; Review
Journal Info: Publisher: Elsevier Scientific Publishers Country of Publication: Netherlands NLM ID: 8916049 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1879-0461 (Electronic) Linking ISSN: 10408428 NLM ISO Abbreviation: Crit Rev Oncol Hematol Subsets: MEDLINE
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 41967618
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Therapeutic sequencing and role of cabozantinib after immunotherapy in metastatic renal cell carcinoma.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Catalano+M%22">Catalano M</searchLink>; Department of Health Sciences, Section of Clinical Pharmacology and Oncology, University of Florence, Viale Pieraccini, 6, Florence 50139, Italy.<br /><searchLink fieldCode="AU" term="%22Venturini+J%22">Venturini J</searchLink>; Department of Experimental and Clinical Medicine, University of Florence, Florence, Italy.<br /><searchLink fieldCode="AU" term="%22Vascotto+IA%22">Vascotto IA</searchLink>; Department of Experimental and Clinical Medicine, University of Florence, Florence, Italy.<br /><searchLink fieldCode="AU" term="%22Sthembari+K%22">Sthembari K</searchLink>; Department of Experimental and Clinical Medicine, University of Florence, Florence, Italy.<br /><searchLink fieldCode="AU" term="%22Mancini+S%22">Mancini S</searchLink>; Department of Experimental and Clinical Medicine, University of Florence, Florence, Italy.<br /><searchLink fieldCode="AU" term="%22Pratesi+L%22">Pratesi L</searchLink>; Department of Experimental and Clinical Medicine, University of Florence, Florence, Italy.<br /><searchLink fieldCode="AU" term="%22Paulet+A%22">Paulet A</searchLink>; Department of Experimental and Clinical Medicine, University of Florence, Florence, Italy.<br /><searchLink fieldCode="AU" term="%22Mela+MM%22">Mela MM</searchLink>; Careggi University Hospital, Clinical Oncology, Florence, Italy.<br /><searchLink fieldCode="AU" term="%22Rossi+V%22">Rossi V</searchLink>; Careggi University Hospital, Clinical Oncology, Florence, Italy.<br /><searchLink fieldCode="AU" term="%22Pillozzi+S%22">Pillozzi S</searchLink>; Department of Experimental and Clinical Medicine, University of Florence, Florence, Italy.<br /><searchLink fieldCode="AU" term="%22Antonuzzo+L%22">Antonuzzo L</searchLink>; Department of Experimental and Clinical Medicine, University of Florence, Florence, Italy; Careggi University Hospital, Clinical Oncology, Florence, Italy.<br /><searchLink fieldCode="AU" term="%22Roviello+G%22">Roviello G</searchLink>; Department of Health Sciences, Section of Clinical Pharmacology and Oncology, University of Florence, Viale Pieraccini, 6, Florence 50139, Italy. Electronic address: giandomenico.roviello@unifi.it.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%228916049%22">Critical reviews in oncology/hematology</searchLink> [Crit Rev Oncol Hematol] 2026 Jul; Vol. 223, pp. 105334. <i>Date of Electronic Publication: </i>2026 Apr 10.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article; Review
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Elsevier+Scientific+Publishers%22">Elsevier Scientific Publishers </searchLink><i>Country of Publication: </i>Netherlands <i>NLM ID: </i>8916049 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1879-0461 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2210408428%22">10408428 </searchLink><i>NLM ISO Abbreviation: </i>Crit Rev Oncol Hematol <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=41967618
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1016/j.critrevonc.2026.105334
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 105334
    Titles:
      – TitleFull: Therapeutic sequencing and role of cabozantinib after immunotherapy in metastatic renal cell carcinoma.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Catalano M
      – PersonEntity:
          Name:
            NameFull: Venturini J
      – PersonEntity:
          Name:
            NameFull: Vascotto IA
      – PersonEntity:
          Name:
            NameFull: Sthembari K
      – PersonEntity:
          Name:
            NameFull: Mancini S
      – PersonEntity:
          Name:
            NameFull: Pratesi L
      – PersonEntity:
          Name:
            NameFull: Paulet A
      – PersonEntity:
          Name:
            NameFull: Mela MM
      – PersonEntity:
          Name:
            NameFull: Rossi V
      – PersonEntity:
          Name:
            NameFull: Pillozzi S
      – PersonEntity:
          Name:
            NameFull: Antonuzzo L
      – PersonEntity:
          Name:
            NameFull: Roviello G
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 07
              Text: 2026 Jul
              Type: published
              Y: 2026
          Identifiers:
            – Type: issn-electronic
              Value: 1879-0461
          Numbering:
            – Type: volume
              Value: 223
          Titles:
            – TitleFull: Critical reviews in oncology/hematology
              Type: main
ResultId 1